These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 9679835)

  • 1. Recurrence of immunological markers for type 1 (insulin-dependent) diabetes mellitus in immunosuppressed patients after pancreas transplantation.
    Esmatjes E; Rodríguez-Villar C; Ricart MJ; Casamitjana R; Martorell J; Sabater L; Astudillo E; Fernández-Cruz L
    Transplantation; 1998 Jul; 66(1):128-31. PubMed ID: 9679835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glutamic acid decarboxylase antibodies are more frequent than islet cell antibodies in islet transplanted IDDM patients and persist or occur despite immunosuppression.
    Jaeger C; Hering BJ; Hatziagelaki E; Federlin K; Bretzel RG
    J Mol Med (Berl); 1999 Jan; 77(1):45-8. PubMed ID: 9930926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Islet cell antibodies and glutamic acid decarboxylase antibodies in patients with insulin-dependent diabetes mellitus undergoing kidney and islet-after-kidney transplantation.
    Jaeger C; Hering BJ; Dyrberg T; Federlin K; Bretzel RG
    Transplantation; 1996 Aug; 62(3):424-6. PubMed ID: 8779696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do glutamic acid decarboxylase antibodies improve the prediction of IDDM in first-degree relatives at risk for IDDM?
    Schmidli RS; Colman PG; Harrison LC
    J Autoimmun; 1994 Dec; 7(6):873-9. PubMed ID: 7888043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reactivation of type 1 diabetes in patients receiving human fetal pancreatic tissue transplants without immunosuppression.
    Brooks-Worrell BM; Peterson KP; Peterson CM; Palmer JP; Jovanovic L
    Transplantation; 2000 Jan; 69(1):166-72. PubMed ID: 10653397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progressive islet graft failure occurs significantly earlier in autoantibody-positive than in autoantibody-negative IDDM recipients of intrahepatic islet allografts.
    Jaeger C; Brendel MD; Hering BJ; Eckhard M; Bretzel RG
    Diabetes; 1997 Nov; 46(11):1907-10. PubMed ID: 9356046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined analysis of islet cell antibodies that cross-react with mouse pancreas, antibodies to the M(r) 64,000 islet protein, and antibodies to glutamate decarboxylase in type I diabetic patients.
    Chaillous L; Delamaire M; Martignat L; Maugendre D; Marre M; Mathieu E; Limal JM; Charbonnel B; Allannic H; Saï P
    Diabetes Care; 1994 Oct; 17(10):1115-23. PubMed ID: 7821130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetics of diabetes-associated autoantibodies after sequential intraportal islet allograft associated with kidney transplantation in type 1 diabetes.
    Vantyghem MC; Fajardy I; Pigny P; Noel C; Kerr-Conte J; Gmyr V; Vandewalle B; Proye C; Pattou F
    Diabetes Metab; 2003 Dec; 29(6):595-601. PubMed ID: 14707888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance and time course of antibodies to glutamic acid decarboxylase in Japanese children with type I (insulin-dependent) diabetes mellitus.
    Sugihara S; Konda S; Wataki K; Kobayashi Y; Murata A; Miyamoto S; Kubo H; Yamaguchi A; Sasaki N; Niimi H
    Acta Paediatr; 1996 May; 85(5):558-63. PubMed ID: 8827099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-GAD antibodies in Chinese patients with youth and adult-onset IDDM and NIDDM.
    Thai AC; Ng WY; Loke KY; Lee WR; Lui KF; Cheah JS
    Diabetologia; 1997 Dec; 40(12):1425-30. PubMed ID: 9447950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin and islet autoantibodies after pancreas transplantation.
    Dieterle CD; Hierl FX; Gutt B; Arbogast H; Meier GR; Veitenhansl M; Hoffmann JN; Landgraf R
    Transpl Int; 2005 Dec; 18(12):1361-5. PubMed ID: 16297055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Islet cell-specific autoantibodies as potential markers for recurrence of autoimmune type 1 diabetes after simultaneous pancreas-kidney transplantation.
    Lohmann T; Klemm T; Geissler F; Uhlmann D; Ludwig S; Hauss J; Witzigmann H
    Transplant Proc; 2002 Sep; 34(6):2249-50. PubMed ID: 12270385
    [No Abstract]   [Full Text] [Related]  

  • 13. Antibodies to glutamic acid decarboxylase in at-risk and clinical insulin-dependent diabetic subjects: relationship to age, sex and islet cell antibody status, and temporal profile.
    Schmidli RS; DeAizpurua HJ; Harrison LC; Colman PG
    J Autoimmun; 1994 Feb; 7(1):55-66. PubMed ID: 8198702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reactivation of type 1 diabetes in patients receiving human fetal pancreatic tissue transplants without immunosuppression.
    Brooks-Worrell BM; Peterson KP; Peterson CM; Palmer JP; Jovanovic L
    Transplantation; 2000 May; 69(9):1824-9. PubMed ID: 10830218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Islet cell autoimmunity in type I diabetic patients after HLA-mismatched pancreas transplantation.
    Bosi E; Bottazzo GF; Secchi A; Pozza G; Shattock M; Saunders A; Gelet A; Touraine JL; Traeger J; Dubernard JM
    Diabetes; 1989 Jan; 38 Suppl 1():82-4. PubMed ID: 2642861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Young age and HLA markers enhance the risk of progression to type 1 diabetes in antibody-positive siblings of diabetic children.
    Yamamoto AM; Deschamps I; Garchon HJ; Roussely H; Moreau N; Beaurain G; Robert JJ; Bach JF
    J Autoimmun; 1998 Dec; 11(6):643-50. PubMed ID: 9878086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pancreas and kidney transplantation: long-term metabolic results].
    Fernández-Cruz L; Pérez M; Astudillo E; Ricart MJ
    Ann Chir; 2001 Jul; 126(6):515-25. PubMed ID: 11486534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoantibodies associated with presymptomatic insulin-dependent diabetes mellitus in women.
    Whittingham S; Byron SL; Tuomilehto J; Zimmet PZ; Myers MA; Vidgren G; Rowley MJ; Feeney SJ; Koskela P; Tuomilehto-Wolf E; Mackay IR
    Diabet Med; 1997 Aug; 14(8):678-85. PubMed ID: 9272595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibodies to glutamic acid decarboxylase and insulin-dependent diabetes in patients with autoimmune polyendocrine syndrome type I.
    Tuomi T; Björses P; Falorni A; Partanen J; Perheentupa J; Lernmark A; Miettinen A
    J Clin Endocrinol Metab; 1996 Apr; 81(4):1488-94. PubMed ID: 8636356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of islet-specific autoantibodies in Japanese patients with insulin-dependent diabetes mellitus: a comparison between autoantibodies to glutamic acid decarboxylase, autoantibodies to 64 kDa islet cell protein and islet cell antibodies.
    Kawasaki E; Takino H; Yano M; Uotani S; Matsumoto K; Yamaguchi Y; Akazawa S; Nagataki S
    J Autoimmun; 1994 Dec; 7(6):791-802. PubMed ID: 7888036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.